AMT + ISO Exercise Calculator
Open →Plan Varda Space ISO exercise around the AMT bargain element. Federal + state, AMT crossover, multi-year credit recovery.
Deep dive: Four AMT mistakes you can still fix before December 31 →Varda Space is pre-IPO. Plan your AMT and NSO exercise tax at any valuation: current 409A FMV, expected IPO price, or post-IPO scenarios.
Beta · invite-only · AlphaLatitude Inc. · Free Tools
Plan Varda Space ISO exercise around the AMT bargain element. Federal + state, AMT crossover, multi-year credit recovery.
Deep dive: Four AMT mistakes you can still fix before December 31 →Left Varda Space with vested ISOs? Model the 90-day exercise-or-forfeit window: your deadline, AMT cost of exercising at once, and the share count that maximizes after-tax value.
Varda Space NSO exercise tax (federal, state, FICA) plus a sell-vs-hold comparison for long-term capital gains.
Deep dive: Six NSO mistakes your tax advisor probably won't mention →Don't work at Varda Space? Find another company.
Varda Space is a privately held Aerospace/Defense company, headquartered in El Segundo, CA.
Last reported secondary-market price: $24.86 per share (as of 2026-06-06). Your own 409A may differ.
In-space manufacturing.
Equity grants at Varda Space typically include incentive stock options (ISOs) and non-qualified stock options (NSOs).
Varda Space Industries, Inc is an American privately held space research company headquartered in El Segundo, California. Founded in January 2021, the company designs, builds, and flies spacecraft that process pharmaceuticals in microgravity. The company targets small molecule crystallization, which is difficult to produce in Earth's gravity, and brings those crystals back to Earth with their atmospheric reentry vehicle. Investors in the company include venture capitalists such as Khosla Ventures and Peter Thiel's Founders Fund.
Source: Wikipedia (CC BY-SA 4.0)
Founded in 2020 by Will Bruey (ex-SpaceX) and Founders Fund partner Delian Asparouhov, Varda Space Industries operates from El Segundo, California, producing pharmaceuticals in microgravity and flying hypersonic re-entry capsules under its W-Series platform. The W-1 capsule returned ritonavir crystals to Utah in 2024, and W-2 launched on SpaceX Transporter-12 in January 2025, landing at Koonibba, Australia in February with an AFRL plasma spectrometer. DoD hypersonic test contracts complement commercial drug work. A $187M Series C in July 2025 lifted total funding to roughly $329M.
Sources: en.wikipedia.org · spacenews.com
OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by Varda Space.
Type a company or ticker. We'll route you to its hub of relevant calculators.
197 of 198 companies
OptionsAhoy plans your Varda Space equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.